Generic Name and Formulations:
Ketorolac tromethamine 10mg; tabs.
Company:
Various generic manufacturers
Use tabs only as continuation therapy to inj. Do not exceed 5 days' combined (inj + tabs) therapy or recommended dose (may use as-needed opioids for breakthrough pain if appropriate). After inj therapy: 16–65yrs (normal renal function): 20mg once then 10mg every 4–6 hours; max 40mg/day. ≥65yrs, or <110lbs, or renal impairment: 10mg every 4–6 hours; max 40mg/day.
<16yrs: not recommended.
Aspirin allergy. Peptic ulcer. GI bleed or perforation. Advanced renal impairment. Hypovolemia. Pre-op or intra-operative use when hemostasis is critical. Cerebrovascular bleeding. Hemorrhagic diathesis. Incomplete hemostasis. Bleeding disorders or high risk of bleeding. Concomitant probenecid, salicylates, other NSAIDs. Epidural or intrathecal inj. Labor & delivery. Late pregnancy. Nursing mothers.
Not for pre-op use. Renal or hepatic dysfunction. Discontinue if abnormal liver function tests occur. Correct hypovolemia first. Hypertension. Cardiac decompensation. Coagulation disorders. May prolong bleeding time. Asthma. Elderly. Debilitated. Children: increased risk of bleeding after tonsillectomy. Pregnancy (Cat.C).
See Contraindications. Monitor anticoagulants closely. Antagonizes furosemide, possibly antiepileptics. May increase serum lithium, methotrexate levels. ACEIs, diuretics increase renal toxicity risk. Hallucinations with fluoxetine, thiothixene, alprazolam. Apnea with non-depolarizing muscle relaxants.
Headache, GI pain/fullness, dyspepsia, other GI effects, dizziness, drowsiness, edema, inj site pain, hypertension, pruritus, rash, stomatitis, purpura, sweating, peptic ulcer, GI bleed/perforation, bleeding, renal or liver failure, anaphylaxis.
Formerly known under the brand name Toradol.
Contact supplier.